Citius Pharmaceuticals Announces Key Management Realignment to Support Commercialization of Two Late-Stage Product Candidates

/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development...

Related Keywords

United States ,Ilanit Allen ,Jaime Bartushak ,Myron Holubiak ,Jamie Bartushak ,Michael Mcguire ,Leonard Mazur ,Leonard Meron Biosciences ,Company Nasdaq ,Medicines Company ,Biomedical Advanced Research ,Program Leader For Anti ,Development Authority ,Exchange Commission ,Government Affairs ,Centers For Medicare ,Corporate Communications ,Securities Exchange ,Citius Pharmaceuticals Inc ,Investor Relations For Citius Pharmaceuticals ,Medicaid Services ,Executive Vice Chairman ,Chief Financial Officer ,Chief Business ,Program Leader ,Citius Pharmaceuticals ,Executive Chairman ,Chief Financial Officer Jaime Bartushak ,While President ,Roche Laboratories ,Citiu Chief Financial Officer ,Chief Executive Officer ,Senior Vice President Commercial ,Customer Engagement ,Senior Vice President ,Global Infectious Disease ,Securities Act ,Securities Exchange Act ,Annual Report ,Investor Relations ,Nc ,